首页> 外文期刊>European journal of endocrinology > TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation
【24h】

TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation

机译: tert 启动子突变:在Tunea Cabitis照射的背景下发生良性和恶性甲状腺肿瘤的遗传特征

获取原文
           

摘要

Objective The aim of this study is to evaluate the frequency and molecular characteristics of TERT p mutations in thyroid adenomas and carcinomas occurring in the low-dose radiation exposure tinea capitis setting. Design and methods Twenty-seven patients with 34 well-differentiated thyroid carcinomas and 28 patients with 29 follicular adenomas diagnosed in a Portuguese tinea capitis cohort were studied. Blood samples were obtained from all the patients. Screening for TERT p mutations was performed by PCR amplification followed by Sanger sequencing. A series of 33 sporadic thyroid adenomas was used as control. Results TERT p mutations were detected in six of the 28 patients with adenoma (21.4%) and in four of the 27 patients with carcinoma (14.8%). Three tumours (two carcinomas and one adenoma) had the tandem mutation ?124/?125 GG>AA (30.0%), whereas the remaining seven had the ?124G?>?A. The 20.7% frequency of TERT p mutations in adenomas contrasts with the absence of mutations in the adenomas from the control group and from most series on record, whereas the one found in carcinomas (11.8%) is similar to those reported in the literature for sporadic carcinomas. Conclusion TERT p mutations, including the tandem mutation ?124/?125 GG>AA not described previously in thyroid tumours, appear to represent a genetic signature for thyroid tumours in patients submitted to low-dose X-ray irradiation. The high frequency of TERT p mutations in the adenomas of our cohort contrasts with their absence in sporadically occurring, as well as in adenomas of the Chernobyl series.
机译:目的本研究的目的是评估甲状腺腺瘤中TERT P突变的频率和分子特征,并在低剂量辐射曝光TUNEA Cacita环境中发生的癌症。研究了二十七名患有34名良好分化的甲状腺癌和28例患有葡萄牙曲霉素癌群患者的29例患有29例卵泡腺瘤的患者。从所有患者中获得血样。通过PCR扩增进行TERT P突变的筛选,然后进行Sanger测序。一系列33种旋转甲状腺腺瘤用作对照。结果在28例腺瘤(21.4%)中的六个患者中检测到Tert P突变,并在27例癌患者中(14.8%)。三种肿瘤(两个癌和一个腺瘤)具有串联突变?124 /?125 gg> aa(30.0%),而剩下的七个有α124g???a。腺瘤中的20.7%的TERT P突变频率与来自对照组的腺瘤中的突变的缺陷形成对比,并且来自癌症的大多数系列,而在癌症(11.8%)中发现的腺瘤(11.8%)类似于零星的文献中报告的那些癌症。结论TERT P突变,包括串联突变α124/α125g>在甲状腺肿瘤中未描述的AA,似乎代表了提交给低剂量X射线照射的甲状腺肿瘤的遗传患者。我们的队列腺瘤中的Tert P突变的高频率与它们在偶像发生的情况下对比,以及切尔诺贝利系列的腺瘤。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号